EMCURE PHARMACEUTICALS
Back to Cashflow Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹94 Cr | ₹-56 Cr | ₹221 Cr | ₹134 Cr | ₹-172 Cr |
What is the latest Net Cash Inflow / Outflow ratio of EMCURE PHARMACEUTICALS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹94 Cr |
| Mar2025 | ₹-56 Cr |
| Mar2024 | ₹221 Cr |
| Mar2023 | ₹134 Cr |
| Mar2022 | ₹-172 Cr |
How is Net Cash Inflow / Outflow of EMCURE PHARMACEUTICALS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹94 Cr | Positive | |
| Mar2025 | ₹-56 Cr | Negative | |
| Mar2024 | ₹221 Cr | 64.85 | |
| Mar2023 | ₹134 Cr | Positive | |
| Mar2022 | ₹-172 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹42,495.6 Cr | 19.9% | 16.5% | 62.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,963.0 Cr | 2.7% | 1.4% | 4.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹269,451.0 Cr | 4.5% | 6.3% | 50.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,456.0 Cr | 1.8% | -1.3% | 31.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,664.0 Cr | 0.8% | 12.5% | 14.1% | Stock Analytics | |
| CIPLA | ₹113,246.0 Cr | 1.6% | 4.4% | -9.1% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 19.9% |
16.5% |
62.9% |
| SENSEX | 7% |
9.6% |
-6.7% |
You may also like the below Video Courses